DRW Securities’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,700
Closed -$2.43M – 896
2026
Q2
$2.43M Buy
+6,700
New +$2.29M 0.06% 185
2025
Q4
– Sell
-123,500
Closed -$34.8M – 1223
2025
Q3
$34.8M Buy
123,500
+52,800
+75% +$15.3M 0.64% 23
2025
Q2
$19.7M Buy
70,700
+32,400
+85% +$9.18M 0.45% 35
2025
Q1
$11.9M Buy
+38,300
New +$11.3M 0.33% 46

Other funds holding AMGN

DRW Securities's AMGN Position: Q3 2026 in Review

DRW Securities sold out of Amgen (AMGN) in Q3 2026, closing a stake of 3,407 shares — an estimated $1.23M sold.

DRW Securities first reported a position in AMGN in Q4 2017 and held it in 13 quarters. The position peaked at $11.4M in Q3 2025. 3,276 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • DRW Securities reported no remaining Amgen position as of Q3 2026 after selling out during the quarter.
  • DRW Securities sold 3,407 Amgen shares in Q3 2026, an estimated $1.23M.
  • DRW Securities first reported a position in Amgen in Q4 2017 and held it in 13 quarters.
  • DRW Securities's Amgen position peaked at $11.4M in Q3 2025.
  • 3,276 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on DRW Securities's 13F filing for Q3 2026, filed 13 Nov 2026.